[在EGFR突变的高级非小细胞肺癌中免疫疗法的进展]
1Clinical Medical College of Jining Medical University, Jining 272000, China.
Zhongguo fei ai za zhi = Chinese journal of lung cancer
|January 2, 2024
概括
EGFR-TKIs是EGFR突变NSCLC的标准,但发生耐药性. 免疫检查点抑制剂在这些患者中显示出有限的益处,这是由于独特的瘤微环境.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 分子生物学分子生物学
背景情况:
- 皮肤生长因子受体-铁氨酸激酶抑制剂 (EGFR-TKI) 是EGFR突变非小细胞肺癌 (NSCLC) 的第一线治疗方法.
- 对EGFR-TKI的耐药性是一个重大的临床挑战.
- 免疫检查点抑制剂 (ICI) 已经彻底改变了先进的NSCLC治疗,但在EGFR突变NSCLC中表现出有限的疗效.
结论:
- 需要进一步的探索,以确定ICI在EGFR突变NSCLC中的适用性和最佳使用.
- 解读EGFR突变NSCLC的独特TME对于改善治疗策略至关重要.
- 可能需要新的方法来提高ICI在这种患者群体中的疗效.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.0K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.8K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K